Cargando…
Non-pharmacological management options for MAFLD: a practical guide
Lifestyle changes should be the main basis for any treatment for metabolic dysfunction–associated fatty liver disease (MAFLD), aiming to increase energy expenditure, reduce energy intake and improve the quality of nutrients consumed. As it is a multifactorial disease, approaches such as physical exe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031614/ https://www.ncbi.nlm.nih.gov/pubmed/36968655 http://dx.doi.org/10.1177/20420188231160394 |
_version_ | 1784910644535885824 |
---|---|
author | Stefano, José Tadeu Duarte, Sebastião Mauro Bezerra Ribeiro Leite Altikes, Renato Gama Oliveira, Claudia P. |
author_facet | Stefano, José Tadeu Duarte, Sebastião Mauro Bezerra Ribeiro Leite Altikes, Renato Gama Oliveira, Claudia P. |
author_sort | Stefano, José Tadeu |
collection | PubMed |
description | Lifestyle changes should be the main basis for any treatment for metabolic dysfunction–associated fatty liver disease (MAFLD), aiming to increase energy expenditure, reduce energy intake and improve the quality of nutrients consumed. As it is a multifactorial disease, approaches such as physical exercise, a better dietary pattern, and possible pharmacological intervention are shown to be more efficient when used simultaneously to the detriment of their applications. The main treatment for MAFLD is a lifestyle change consisting of diet, activity, exercise, and weight loss. The variables for training prescription such as type of physical exercise (aerobic or strength training), the weekly frequency, and the intensity most indicated for the treatment of MAFLD remain uncertain, that is, the recommendations must be adapted to the clinical conditions comorbidities, and preferences of each subject in a way individual. This review addresses recent management options for MAFLD including diet, nutrients, gut microbiota, and physical exercise. |
format | Online Article Text |
id | pubmed-10031614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-100316142023-03-23 Non-pharmacological management options for MAFLD: a practical guide Stefano, José Tadeu Duarte, Sebastião Mauro Bezerra Ribeiro Leite Altikes, Renato Gama Oliveira, Claudia P. Ther Adv Endocrinol Metab New Insights in MAFLD Lifestyle changes should be the main basis for any treatment for metabolic dysfunction–associated fatty liver disease (MAFLD), aiming to increase energy expenditure, reduce energy intake and improve the quality of nutrients consumed. As it is a multifactorial disease, approaches such as physical exercise, a better dietary pattern, and possible pharmacological intervention are shown to be more efficient when used simultaneously to the detriment of their applications. The main treatment for MAFLD is a lifestyle change consisting of diet, activity, exercise, and weight loss. The variables for training prescription such as type of physical exercise (aerobic or strength training), the weekly frequency, and the intensity most indicated for the treatment of MAFLD remain uncertain, that is, the recommendations must be adapted to the clinical conditions comorbidities, and preferences of each subject in a way individual. This review addresses recent management options for MAFLD including diet, nutrients, gut microbiota, and physical exercise. SAGE Publications 2023-03-21 /pmc/articles/PMC10031614/ /pubmed/36968655 http://dx.doi.org/10.1177/20420188231160394 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | New Insights in MAFLD Stefano, José Tadeu Duarte, Sebastião Mauro Bezerra Ribeiro Leite Altikes, Renato Gama Oliveira, Claudia P. Non-pharmacological management options for MAFLD: a practical guide |
title | Non-pharmacological management options for MAFLD: a practical
guide |
title_full | Non-pharmacological management options for MAFLD: a practical
guide |
title_fullStr | Non-pharmacological management options for MAFLD: a practical
guide |
title_full_unstemmed | Non-pharmacological management options for MAFLD: a practical
guide |
title_short | Non-pharmacological management options for MAFLD: a practical
guide |
title_sort | non-pharmacological management options for mafld: a practical
guide |
topic | New Insights in MAFLD |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031614/ https://www.ncbi.nlm.nih.gov/pubmed/36968655 http://dx.doi.org/10.1177/20420188231160394 |
work_keys_str_mv | AT stefanojosetadeu nonpharmacologicalmanagementoptionsformafldapracticalguide AT duartesebastiaomaurobezerra nonpharmacologicalmanagementoptionsformafldapracticalguide AT ribeiroleitealtikesrenatogama nonpharmacologicalmanagementoptionsformafldapracticalguide AT oliveiraclaudiap nonpharmacologicalmanagementoptionsformafldapracticalguide |